|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.70 USD | +5.42% |
|
+32.70% | +118.92% |
| 07-21 | Barclays Initiates Forte Biosciences at Overweight With $74 Price Target | MT |
| 07-09 | Forte Biosciences, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.46B | - | - | - | - | - |
| 55.92B | |||||
| 56.67B | |||||
| 23.28B | - | ||||
| 23.28B | - | ||||
| 20.54B |
Select your edition
All financial news and data tailored to specific country editions
